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Introduction: Breast surgery is associated with persistent postsurgical pain; usually related to
poorly treated acute pain. Paravertebral block has been successfully employed in analgesic proto-
cols for breast surgery; its impact on postdischarge pain (PDP) has not been investigated. The aimof
this study was to assess characteristics of PDP after breast surgery, the development of chronic
postoperative pain (CPP) and its impact on health care costs.
Methods:We conducted a retrospective, observational study on a continuous cohort of adult
female patients undergoing local breast cancer surgery under combined anesthesia. All
patients were interviewed 6 months after hospital discharge. The survey was speciﬁcally
conceived to assess incidence, features and duration of PDP. The overall cost of additional
healthcare resources consumed with a speciﬁc relationship to persistent PDP was estimated.
Results: A database of 244 patients was preliminarily analyzed. Of these, 188 were
included in the following statistical analysis; 123 patients (65.2%) reported signiﬁcant
PDP, with a median intensity on NRS of 6 (IQR=2), more frequently described as
burning and associated with paresthesia and/or hyperalgesia (87 patients, 46%). One
hundred and six patients (56.5%) reported this pain as interfering with their normal
daily activities, work and sleep. In 26.8% of cases (50 patients) symptoms lasted more
than 1 month and in 28 patients (15.0%) pain became chronic. The majority of patients
self-treated their pain with non-steroideal anti-inﬂammatory drugs, but in 50 patients
(26.8%) this therapy was reported as ineffective. This additional consumption of health
care resources led to a signiﬁcant economical impact.
Conclusion: PDP and CPP seem to be common complications after breast cancer
surgery, even if a combined anesthesia technique with a thoracic paravertebral block is
performed, leading to severe consequences on patients’ quality of life and increasing
consumption of healthcare resources after discharge.
Trial number: NCT03618459 (www.clinicaltrials.gov).
Keywords: breast surgery, paravertebral block, regional anesthesia, postoperative pain
Introduction
Breast cancer is the most frequently diagnosed tumor in women, with an incidence of
more than one million new cases per year.1 Surgery is often part of the treatment, and the
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prognosis has progressively improved during the last decade.
There is an increasing interest in patients’ life quality after
surgery, on which pain has a huge impact. In fact, breast
surgery is associated with a high prevalence of chronic post-
operative pain (CPP).2 Patients complain about persistent
painful sensation in correspondence of the surgical wound,
lasting beyond 2 months since the surgical intervention. This
has progressively emerged as a relatively frequent delayed
complication of breast surgery, being its prevalence of up to
60%.2 Moreover, this disabling condition signiﬁcantly
affects cancer survivors’ quality of life3,4 and to have an
impact on healthcare costs.5,6
Development of chronic postbreast surgery pain is
associated with some potential risk factors.2 Of all the
predictors of CPP, which have been currently identiﬁed
in the literature as local pain persisting more than 2
months after surgery,7 a recurring risk factor seems to
be poorly treated acute pain.7,8
Recently, the awareness of the social impact of
untreated postoperative pain is broadening the debate
regarding the translation from chronic wound pain to per-
sistent postoperative pain;7 the latter, even if not meeting
the criteria to be classiﬁed as chronic, has been recognized
as a major cause of unexpected hospital readmission and
a detrimental factor affecting patients’ quality of life.7,9
A Cochrane systematic review has addressed the
role of regional anesthesia in preventing the develop-
ment of CPP, suggesting that “paravertebral block may
reduce the pain after breast cancer surgery in about one
out of ﬁve women treated“, these results being however
weakened by a poor quality or an inadequate power of
the studies included.10,11 The mechanism underlying of
regional anesthesia could be a preventive effect on the
remodeling of the nervous system, which occurs when
a persistent nociceptive stimulus is applied and often
results in hyperalgesia, allodynia and a sustained
wound pain.11
Even though CPP has been progressively recognized as
a signiﬁcant clinical issue after breast cancer surgery,12 the link
between the anesthetic regimen and the postdischarge pain
(PDP) has been poorly investigated. Single-shot paravertebral
block is an effective technique to provide postoperative
analgesia in the ﬁrst postoperative hours after breast surgery,
especially in patients who are not undergoing axillary surgery,
but its long-term beneﬁts are still debated.8 The aim of this
study is to assess incidence, characteristics and both clinical
and economic consequences of PDP, as well as its correlation
with the incidence of CPP development in a continuous cohort
of patients undergoing local breast cancer surgery in
a standardized combined anesthesia regimen, including
a single-shot analgesic paravertebral block.
Material and methods
We performed a retrospective observational study on
a consecutive cohort of female adult patients who under-
went local breast cancer surgery with a standardized com-
bined anesthesia technique, including a standardized
single-shot thoracic paravertebral block performed before
surgery with a long-lasting local anesthetic and general
anesthesia, which is described in more detail in the section
below.
As part of the local quality survey aimed at assessing
patients’ satisfaction with speciﬁc regard to the quality of
postoperative analgesia after breast surgery, all patients
undergoing breast cancer surgery were systematically tele-
phone interviewed 6 months after hospital discharge. The
survey, conducted after the inclusion of paravertebral
block in the postoperative analgesia protocol for breast
cancer surgery, was speciﬁcally aimed at assessing,
besides overall satisfaction, the incidence, features and
duration of an eventual PDP. Answers to the questionnaire
were anonymously registered in an electronic database.
After approval by the Institutional Review Board of the
Hospital (Bellinzona Regional Hospital, Bellinzona,
Switzerland)Ospedale Regionale di Bellinzona e Valli, an
observational retrospective cohort study was conducted on
the results of the survey. The study was registered on
Clinicaltrial.gov (number NCT03618459) and was carried
out according to the principles of the Declaration of Helsinki.
Inclusion criteria for the analytic cohort were: 1) consecutive
ASA 1–3 adult female patients, 2) elective local breast surgery,
namely unilateral tumor resections, lumpectomies or mastec-
tomies, without axillary lymphadenectomy, 3) under
a combined anesthesia with a standardized single-shot thoracic
paravertebral block and 4) who completed the telephone inter-
view 6months after surgery. Patients were excluded if any data
at any time regarding their pain evolution and medications
were incomplete.
Combined anesthesia
All patients underwent the same standardized anesthetic treat-
ment, according to a speciﬁc protocol. After arrival in the
preoperative induction room, standard monitoring and periph-
eral venous access were attained. A standard procedural intra-
venous analgesia and sedation was administered, with 1 μg/kg
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of fentanyl and 1–2 mg of midazolam. All patients underwent
an ultrasound-guided unilateral thoracic paravertebral block
both at TH3 and TH4 level using an in-plane approach with
a 5 cm needle (Contiplex D, B. Braun Medical Inc.,
Melsungen, Germany), according to a standardized procedure.
After a preliminary orientation scan aimed at identifying the
correct levels and prior to the procedure, skin disinfection was
performed with a two-layer application of an alcoholic povi-
done-iodine solution (Betaseptic®, Mundipharma, Basel,
Switzerland). Three minutes later, the area of the puncture
point was covered with sterile drapes. After conﬁrmation of
correct positioning of the needle tip with the administration of
a small bolus of normal saline under ultrasound guidance and
after negative aspiration, two boluses of 10 mL of ropivacaine
0.75% (Naropine, AstraZeneca plc, London, UK) were admi-
nistered both at TH3 and TH4, for a total volume of 20 mL,
under real-time ultrasound visualization. Block success was
subsequently evaluated with thermal sensation testing: a block
was deﬁned as successful when associated with a complete
loss of cold perception overall dermatomes involved in the
planned surgery 20 mins after local anesthetic injection.
Thereafter, total intravenous anesthesia was induced
after further administration of 1–2 mcg/kg of fentanyl
prior to laryngeal mask placement. During general
anesthesia, all patients received a single dose of diclofenac
75 mg and paracetamol 1 g intravenously as per local
protocol. Systemic postoperative analgesia with oral diclo-
fenac (50 mg tid) and paracetamol (1 g qd) was always
prescribed during the whole hospital stay.
Questionnaire
Data were collected with a speciﬁc questionnaire, including
information such as the date of surgery, type and site of
surgery, and basal patients’ demographic data. Patients were
subsequently contacted by phone at home, 6 months after
surgery, concerning their pain’s evaluation and the adequacy
of own postoperative analgesia during the ﬁrst 24 hrs after
surgery, stratifying it into categorical variables as insufﬁcient,
sufﬁcient, good or perfect. The analgesic protocol was con-
sidered as effective when patients evaluated their analgesia as
sufﬁcient, good or perfect.
Patients were subsequently asked to discuss the occurrence
of PDP. PDP was evaluated by Numerical Rating Scale (NRS,
from 0 intended as no pain, to 10 as maximal pain), deﬁning
“pain” any ache referred as “more than 2”. Data regarding
PDP duration and its characteristics (burning versus stubbing,
associated with paresthesia or to any neurologic symptom),
localization (local and/or regional and relative distribution),
impact on daily life activity (particularly on work, leisure time
or sleep) and treatment (classiﬁed according to use of para-
cetamol and/or non-steroideal anti-inﬂammatory drugs
(NSAID) and/or oral opioids) were registered.
Outcome measures
The primary outcome of the study was the incidence of
PDP. Secondary outcomes were: PDP characteristics,
impact on patient daily life after discharge, and the corre-
lation between PDP and the incidence of CPP, deﬁned as
wound pain a period of 3 months after surgery. Another
secondary outcome was the postoperative healthcare costs
associated with analgesic drugs consumption and consulta-
tions with the general practitioners related to pain issues.
Statistics
Unpaired Student's t-test was used for parametric data null
hypothesis testing, while Mann–Whitney U-test was applied
to non-parametric data. A P-value<0.05 was considered sta-
tistically signiﬁcant (95%CI). Results are given asmean (m) ±
SD for normally distributed parameters or median (M) and
relative IQR for non-normally distributed parameters. A Chi-
square test was performed in order to evaluate any statistical
correlation between PDP andCPP. The economic analysis was
performed assuming the point of view of the community. Post
discharge healthcare costs were evaluated with a top-down
technique by computing the costs of consultations by general
practitioners (based on recall from patients) and analgesic
drugs. The costs of lost working days due to pain-related
disabilities were not taken into account. Costs were expressed
in USD. Statistical analysis was performed using SPSS (IBM
Corporation, Armonk, NY, USA) and Numbers ’09 2.1 ver-
sion (Apple Inc., Bellinzona, Switzerland) software. All data
were collected and stored anonymously in an electronic pro-
tected database.
Results
Of 244 consecutive questionnaires, 56 were excluded
because incomplete, while 188 were considered in the
ﬁnal analysis. The main characteristics of the population
were: mean age 58.9±14.6 years, median ASA class 2
(IQR=1) and mean length of hospital stay 6±1 days.
After discharge at home, 70.2% (N=132) of patients
referred localized (uniquely at the site of the surgical wound)
or regional PDP radiating to the ipsilateral arm (Table 1).
Median PDP intensity on NRS was 6 (IQR=2), and pain was
more frequently described as burning and associated with
paresthesia and/or hyperalgesia (46%), rather than stabbing,
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suggesting a neuropathic component. In a signiﬁcant propor-
tion of patients (14.9%) PDP had a negative impact on many
aspects of their lives, such as sleep, recreational activities and
work abilities, but patients were hardly able to point out only
one of these aspects as predominant over others.
In-hospital pain treatment
Regarding efﬁcacy of acute pain treatment the day after
surgery, patients evaluated their analgesia at awakening
from general anesthesia as perfect in 49%, good in
38%, sufﬁcient in 10% and inadequate in 3% of cases
(Figure 1). Acute pain management was thus consid-
ered adequate in about 97% of patients. Regarding
patients’ analgesia over the whole hospitalization
assessed during phone recall, patients rated it as perfect
in 37% of cases, good in 55% of cases, sufﬁcient in
5% of cases and inadequate in 3% of patients (Figure
2). Overall inpatient analgesia was then considered
adequate in 97% of patients.
PDP and chronic pain
In 26.6% of patients (n=50), PDP persisted for more than 1
month and in 14.9% (n=28) pain became chronic, longer
than 3 months duration; in 8.5% of these (n=16), PDP was
still present during the interview (Figure 3). Good in-
hospital analgesia did not seem to prevent the development
of PDP: most of the patients considered their in-hospital
analgesia as at least sufﬁcient.
A high correlation was found between PDP and the devel-
opment of CPP: all patients (188 patients, 100%) developing
a CPP referred to having suffered from PDP immediately after
home discharge. No patient who was PDP-free after discharge
subsequently developed a CPP (p<0.001).
PDP and healthcare costs
The majority of patients affected by PDP (123 patients,
65.2%) treated their pain with a combination of paraceta-
mol and NSAIDs – the most common was diclofenac; in
26.7% of cases (50 patients) this therapy was ineffective
and 18.8% of patients went to their general practitioner for
a consultation related to their PDP. During the ﬁrst 6
months postoperatively, postdischarge costs of home-
based systemic analgesia and eventual general practitioner
consultations related to pain issues were signiﬁcantly
higher in patients with PDP compared to patients without
PDP, with an estimated increase in healthcare related costs
per patient over the ﬁrst 6 postdischarge months of 1,367
USD, due to medications (about 900 USD for 6 months)
and consultation with general practitioners speciﬁcally
attributable to PDP or PDP-related issues (about 400
USD during 6 months).
Discussion
The preventive role of regional anesthesia onCPP in relation to
its effective control of acute pain has often been postulated.
Hussain et al,11 have shown that a combined anesthesia regi-
men including a paravertebral block to be associated with
a better acute postoperative analgesia compared to controls.
However, regional anesthesia does not exclude the possibility
to develop a persistent wound pain. Little is known about the
characteristics and the duration of PDP in this particular popu-
lation, undergoing breast cancer surgery with a paravertebral
block, which was the aim of this study. In this study, both PDP
and CPP after breast surgery have been shown to be common,
Table 1 Primary outcome and main secondary outcomes
Primary outcome
PDP incidence, no. (%) 132 (70.2%)
Secondaries outcomes
PDP intensity, median (IQR) 6 (2)
PDP characteristic Burning with paresthesia/hyper-
algesia (46%)
Disability incidence, no. (%) 28 (14.9%)
Pain 24 hrs after surgery Perfect 49%
Good 38%
Sufﬁcient 10%
Insufﬁcient 3%
Pain treatment during whole glo-
bal stay
Perfect 37%
Good 55%
Sufﬁcient 5%
Insufﬁcient 3%
PDP, no. (%) More than 1 month 50
(26.6%)
More than 3 months 28
(14.9%)
At 6 months 16
(8.5%)
Pharmacologic treatment, no. (%) Self treated 123
(65.2%)
Treated but not
efﬁcacy
50
(26.7%)
Treated and need
a visit
35
(18.8%)
Notes: For details, please refer to the text. “Disability incidence” is deﬁned as
severe impairment of daily activities.
Abbreviation: PDP, postdischarge pain.
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also when a combined anesthesia technique is adopted, with
a single-shot thoracic paravertebral block performed before
induction. In particular, PDP was referred by the majority of
the patients interviewed and had an important negative impact
on their quality of life, affecting both normal working activity
and sleeping in a very high percentage of cases. Pain incidence
in this study is actually quite low compared to prior studies on
this topic;11 this is likely due to the employed regional anesthe-
sia, but it is possible that the incidence of pain may be less
frequently depending on differences about demographic data
(like age), postoperative acute treatment and pain deﬁnition.
A single shot paravertebral block seems to be a good choice
to provide effective in-hospital analgesia during the ﬁrst days
after surgery, but does not seem to prevent the development of
PDP in the following period.
PDP duration was extremely variable, often lasting for
many weeks after surgery and evolving into chronic pain
syndrome in 15%of cases. Patients generally attempted to self-
54.10%
26.80%
15.00%
8.50%
At discharge At 1 month At 3 months At 6 months
Figure 1 Percentage of patients affected by postdischarge pain at discharge, at 1 month, at 3 months and during the interview at 6 months. Median Numerical Rating Scale
pain perception was 6 (IQR=2).
Sufficient
5%
Perfect
37%
Good
55%
Insufficient
3%
Figure 2 Patients’ evaluation of regional anesthesia effect. Regional anesthesia was
considered adequate if evaluated as sufﬁcient, good or perfect.
Insufficient
3% Sufficient
10%
Good
38%
Perfect
49%
Figure 3 Global intra-hospital analgesia efﬁcacy, evaluated by patients. Global
analgesia was considered adequate if evaluated as sufﬁcient, good or perfect.
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medicate PDP with NSAIDs, treatment turning out to be
ineffective and leading eventually to a visit to the family
practitioner, with an obvious impact on patient’s life quality
and total healthcare costs.
Previous studies focused on CPP incidence, while this is
the ﬁrst study speciﬁcally addressing PDP after local breast
surgery, with the aim of quantifying and characterizing this
condition, its dimension and gravity of which was found to
be a potentially important healthcare issue. Our ﬁnding sup-
ports the hypothesis that, even when a good anesthetic plan is
routinely adopted and includes regional anesthesia technique
such as a single shot-paravertebral block with a long-lasting
local anesthetic, PDP is not prevented. Moreover, CPP
whose incidence is still high in this speciﬁc group of patients
is also not prevented by a single-shot paravertebral block.
PDP in breast surgery patients seemed to have speciﬁc
neuropathic features, which is a signiﬁcant subgroup of
patients interviewed had an important and prolonged
impact on quality of life and possibly on postdischarge
healthcare costs, ultimately causing a sustained use of
analgesic drugs and consultations by general practitioners
for pain-related issues. It is important to notice that our
patients were not enrolled in a fast-track program and
stayed in the hospital for several days before discharge
home. During their hospitalization, they received systemic
analgesia with NSAID, paracetamol and rescue opioids on
demand, according to a standard protocol. However, even
if patients remained in hospital and were monitored for
days, being regularly treated with analgesic drugs, PDP
and the development of CPP were not prevented.
Chronic pain iswell known to be a public health issue: 22%
of US primary care appointments focus on pain management,
and a linear trend of speciﬁc national pain consultations has
been reported,7,13 showing an increase from 11% to 14% over
the period 2000–2007 in the US. Moreover, patients suffering
from chronic pain resulted in seeing their general practitioners
up to ﬁve times more frequently than other patients.13,14 Total
costs of prescribed pain medication are $17.8 billion annually,
only in the US, and the largest three categories for pain therapy
costs were $1.9 billion for analgesics/NSAIDs, $3.6 billion for
opioids and $12.3 billion for adjuvants.15,16 Unfortunately,
there are no Swiss data available on this speciﬁc topic, despite
that drugs consumptions in Switzerland are known to be the
biggest in Europe and second only to US.17
Further studies are required to deﬁne effective strategies to
treat postoperative pain after breast surgery speciﬁcally aiming
at preventing PDP, eventually decreasing the incidence of
postoperative chronic pain. Regional anesthesia as well as the
preventive use of systemic drugs, such as ketamine, have been
shown by some preliminary evidence to be possibly associated
with a reduction in chronic pain incidence;18 but these data
must still be conﬁrmed by adequately designed and powered
studies, particularly in the context of breast surgery.
Our study has several limitations. Firstly, this was a single-
center retrospective study, including all relative drawbacks
compared to prospective randomized trials. Secondly, only
one analgesicmanagement was studied, making results applic-
able only to this therapeutic management, even if the paraver-
tebral block is considered as an advanced technique to control
acute pain after breast surgery. Moreover, our study does not
stratify patients with regard to eventual postoperative treat-
ments which may potentially inﬂuence the intensity, the char-
acteristics and the duration of postoperative pain, such as
radiotherapy.
For the assessment of the characteristics of PDP,we did not
use a validated scale (like VAS-scale), as we wanted to focus
on a combination of factors, assessing the duration, the inten-
sity and the characteristics of pain. Another limitation is that, in
order to adequately assess PDP and CPP incidence, our ques-
tionnaire was performed 6 months after hospital discharge,
which might have affected patients’ accuracy in assessing
their pain. However, this may also represent an advantage
with regard to the possibility of giving a more detached and
unbiased evaluation of their entire postoperative experience
overall.
Conclusion
PDP and CPP seem to be common complications after
breast surgery even when a general anesthesia technique
is combined with a single-shot thoracic paravertebral
block. Given the impact of these complications on the
patients’ quality of life and healthcare costs, alternative
analgesic strategies and a proper follow-up seem to
be recommendable, in order to prevent or early detect
and adequately treat PDP.
Copyright/Ethics statement
All authors conﬁrm that this study was carried out in
accordance with the principles of the Declaration of
Helsinki. All authors declare that patients provided oral
informed consent for their data to be used in the study. The
Institutional Review Board of the Ospedale Regionale di
Bellinzona e Valli approved the entire study design.
Saporito et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Journal of Pain Research 2019:121198
Data sharing statement
All dataset used and/or analyzed during the current study is
available from the ﬁrst author on reasonable request made by
email for a period of 10 years from the closing of the study.
Acknowledgment
The authors thank Katja Sigrist for her help with the literature
search and study quality assessment, and for her contribution
to the statistical analysis and manuscript critical review.
Author contributions
All authors contributed to data analysis, drafting and revising
the article, gave ﬁnal approval of the version to be published,
and agree to be accountable for all aspects of the work.
Disclosure
The authors report no conﬂicts of interest in this work.
References
1. Cronin-Fenton DP, Norgaard M, Jacobsen J, et al. Comorbidity and
survival of Danish breast cancer patients from 1995 to 2005. Br
J Cancer. 2007;96:1462–1468. doi:10.1038/sj.bjc.6603717
2. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment:
a critical review of risk factors and strategies for prevention. J Pain.
2011;12:725–746. doi:10.1016/j.jpain.2010.12.005
3. Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA. Long-term
follow-up of breast cancer survivors with post-mastectomy pain
syndrome. Br J Cancer. 2005;92:225–230. doi:10.1038/sj.bjc.6602304
4. Peuckmann V, Ekholm O, Rasmussen NK, et al. Chronic pain and
other sequelae in long-term breast cancer survivors: nationwide survey
in Denmark. Eur J Pain. 2009;13:478–485. doi:10.1016/j.
ejpain.2008.05.015
5. Blyth FM, March LM, Brnabic AJ, Cousins MJ. Chronic pain and
frequent use of health care. Pain. 2004;111:51–58. doi:10.1016/j.
pain.2004.05.020
6. Blyth FM, March LM, Cousins MJ. Chronic pain-related disability
and use of analgesia and health services in a Sydney community. Med
J Aust. 2003;179:84–87.
7. Correl D. Chronic postoperative pain: recent ﬁnding in understanding
and management. Research. 2017;6:1054.
8. Schreiber KL, Martel MO, Shnol H, et al. Persistent pain in
postmastectomy patients: comparison of psychophysical, medical,
surgical, and psychosocial characteristics between patients with
and without pain. Pain. 2013;154(5):660–668. doi:10.1016/j.
pain.2012.11.015
9. Pham QH, Li SX, Williams BC, Factors R. Effects of care manage-
ment on hospital readmissions among high users at an academic
medical center. Care Manag J. 2016;17(3):134–139. doi:10.1891/
1521-0987.17.3.134
10. Andreae MH, Andreae DA. Local anaesthetics and regional anaes-
thesia for preventing chronic pain after surgery. Cochrane Database
Syst Rev. 2012;17(10):CD007105.
11. Hussain N, Shastri U, Cjl M, et al. Should thoracic paravertebral
blocks be used to prevent chronic postsurgical pain after breastcancer
surgery? A systematic analysis of evidence in light of IMMPACT
recommendations. Pain. 2018;159(10):1955–1971. doi:10.1097/j.
pain.0000000000001292
12. Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H.
Persistent pain and sensory disturbances after treatment for breast
cancer: six-year nationwide follow-up study. BMJ. 2013;346:f1865.
doi:10.1136/bmj.f1164.
13. Rasu RS, Vouthy K, Crowl AN, et al. Cost of pain medication to treat
adult patients with non-malignant chronic pain in the United States.
J Manag Care Pharm. 2014;20(9):921–928.
14. Physicians Desk Reference. Red Book 2009: Pharmacy’s Fundamental
Reference. 113th ed. Montvale (NJ): Thomson Reuters; 2009.
15. Centers for Disease Control and Prevention. Ambulatory health care
data. Available from: http://www.cdc.gov/nchs/about/major/ahcd/
ahcd1.htm. Accessed June 29, 2014.
16. Smith BH, Torrance N. Management of chronic pain in primary care.
Curr Opin Support Palliat Care. 2011;5(2):137–142. doi:10.1097/
SPC.0b013e328345a3ec
17. Breivik H, Collet B, Ventafridda V, Cohen R, Gallacher D. Survey of
chronic pain in Europe: prevalence, impact on daily life, and
treatment. Eur J Pain. 2006;10(4):287–333. doi:10.1016/j.
ejpain.2005.06.009
18. Jouguelet-Lacoste J, La Colla L, Schilling D, Chelly JE. The use of
intravenous infusion or single dose of low-dose ketamine for postoperative
analgesia: a review of the current literature. Pain Med. 2015;16
(2):383–403. doi:10.1111/pme.12619
Journal of Pain Research Dovepress
Publish your work in this journal
The Journal of Pain Research is an international, peer reviewed, open
access, online journal that welcomes laboratory and clinical ﬁndings in
the ﬁelds of pain research and the prevention and management of pain.
Original research, reviews, symposium reports, hypothesis formation
and commentaries are all considered for publication. The manuscript
management system is completely online and includes a very quick
and fair peer-review system, which is all easy to use. Visit http://
www.dovepress.com/testimonials.php to read real quotes from pub-
lished authors.
Submit your manuscript here: https://www.dovepress.com/journal-of-pain-research-journal
Dovepress Saporito et al
Journal of Pain Research 2019:12 submit your manuscript | www.dovepress.com
DovePress
1199
